Friday Newswire: Alzheimer Research & More

[This article posted on February 12, 2010. It is posted within the following categories: CMS, Corporate, Diversions, Knowledge & Medicine, Pharma & Devices, Politics & The Law, Science & Research, via Michael Douglas, MD, MBA.]
  • The Wellpoint saga continues…as well as the blame game for significant premium hikes.
  • Study: alcohol + energy drinks (like Red Bull) = recipe for disaster.
  • Has the H1N1 pandemic peaked?
  • The first study of the anti-CSF prototypes for treatment/reversal of Alzheimer dementia is underway.
  • The trial will measure in the cerebrospinal fluid (CSF) and blood plasma of amnestic mild cognitively impaired (MCI) patients the biochemical changes that are associated with AD and correlate them with the pharmacokinetics of the drug and its metabolites.

  • For California, the bleeding never ends. Today, Gov. Schwarzenegger releases his spending plan for 2010-11 which details even deeper cuts to its Dept. of Human Services.

Related Posts Within Doctor Pundit:

  1. Friday Newswire: Obama Names New CDC Chief & More NY principal with swine flu very ill. Obama names new...
  2. Friday Newswire: The FDA & Medical Device Approval & More Minnesota man gets prison time for trying to scam one...
  3. Tuesday Newswire: It’s All about Alzheimer Dementia We’ve always known the prevalence of dementia increases with age....
  4. Friday Newswire: Veterans’ Health at Risk in HIV Flap & More Some headlines prior to the Independence Day holiday. Normal posting...
  5. Social Media Research Involving Dementia Revving Up (in Norway) Sign of the times: social media’s use in increasing interaction...

[This article is contained within the following tags:

Leave a Reply